Prior experience with GLP-1 medications provides some guidance but does not guarantee similar experiences with multi-receptor agonists
1a) to measure different types of cysteine oxidation in CSF samples from ALS patients at two time points 4 months apart (visit 1, n = 24 and visit 2, n = 15) compared to healthy controls (HCs) (visit 1, n = 20 and visit 2, n = 11) (Table S1)
In spite of these safety issues, pharmaceutical and medical device companies make billions each year
Notably, in the condition of excess hemin exposure and hypoxia, our findings suggest an important contribution of the TSS pathway and its regulation by DMF for de novo cysteine synthesis and GSH generation in protecting against the oxidative and ferroptotic stresses in SCD erythroblasts
For patients weighing their options, comparing established treatments such as Mounjaro or Zepbound can offer useful context, since both follow a similar philosophy of gradual, provider-guided pacing rather than an immediate jump to a target level
People experiencing problems post complaints and seek support
